Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 510.1
(4.18%)
INR 510.1
(4.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.38 Billion INR | -10.73% |
| 2022 | 14.43 Billion INR | 13.83% |
| 2021 | 12.68 Billion INR | -19.51% |
| 2020 | 15.75 Billion INR | 24.3% |
| 2019 | 12.67 Billion INR | -4.12% |
| 2018 | 13.22 Billion INR | 153.77% |
| 2017 | 5.2 Billion INR | -44.65% |
| 2016 | 9.41 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.63 Billion INR | 21.39% |
| 2024 Q2 | 3.46 Billion INR | -4.55% |
| 2023 Q4 | 2.99 Billion INR | 20.38% |
| 2023 Q1 | 3.52 Billion INR | -7.44% |
| 2023 Q2 | 4.25 Billion INR | 20.7% |
| 2023 FY | 12.88 Billion INR | -10.73% |
| 2023 Q3 | 2.48 Billion INR | -41.51% |
| 2022 Q2 | 3.38 Billion INR | 2.51% |
| 2022 Q4 | 3.8 Billion INR | -3.58% |
| 2022 FY | 14.43 Billion INR | 13.83% |
| 2022 Q1 | 3.3 Billion INR | 2.18% |
| 2022 Q3 | 3.94 Billion INR | 16.66% |
| 2021 Q4 | 3.23 Billion INR | 221.94% |
| 2021 FY | 12.68 Billion INR | -19.51% |
| 2021 Q3 | 1 Billion INR | -75.02% |
| 2021 Q2 | 4.01 Billion INR | -0.98% |
| 2021 Q1 | 4.05 Billion INR | 0.62% |
| 2020 FY | 15.75 Billion INR | 24.3% |
| 2020 Q2 | 3.97 Billion INR | 14.1% |
| 2020 Q1 | 3.48 Billion INR | 43.58% |
| 2020 Q3 | 4.26 Billion INR | 7.33% |
| 2020 Q4 | 4.03 Billion INR | -5.54% |
| 2019 Q4 | 2.42 Billion INR | -29.39% |
| 2019 FY | 12.67 Billion INR | -4.12% |
| 2019 Q3 | 3.43 Billion INR | -2.12% |
| 2019 Q2 | 3.51 Billion INR | 6.35% |
| 2019 Q1 | 3.3 Billion INR | 2.95% |
| 2018 Q4 | 3.2 Billion INR | -9.97% |
| 2018 FY | 13.22 Billion INR | 153.77% |
| 2018 Q1 | 3.02 Billion INR | -0.46% |
| 2018 Q2 | 3.42 Billion INR | 13.05% |
| 2018 Q3 | 3.56 Billion INR | 4.06% |
| 2017 Q4 | 3.04 Billion INR | 0.0% |
| 2017 Q2 | 398.18 Million INR | -84.6% |
| 2017 Q1 | 2.58 Billion INR | 0.0% |
| 2017 FY | 5.2 Billion INR | -44.65% |
| 2016 FY | 9.41 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 97.446% |
| NATCO Pharma Limited | 40.02 Billion INR | 69.056% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -17.79% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -377.693% |
| Achyut Healthcare Limited | 61.36 Million INR | -20079.407% |
| Ajanta Pharma Limited | 42.08 Billion INR | 70.576% |
| Alkem Laboratories Limited | 126.67 Billion INR | 90.224% |
| Alpa Laboratories Limited | 1.08 Billion INR | -1038.865% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 79.739% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 4.411% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 95.686% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -161.585% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -60.779% |
| Brooks Laboratories Limited | 794.86 Million INR | -1457.996% |
| Divi's Laboratories Limited | 78.45 Billion INR | 84.214% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 95.564% |
| Eris Lifesciences Limited | 20.09 Billion INR | 38.362% |
| FDC Limited | 19.42 Billion INR | 36.262% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 89.517% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 45.761% |
| Granules India Limited | 45.06 Billion INR | 72.519% |
| Gufic Biosciences Limited | 8.06 Billion INR | -53.52% |
| Hester Biosciences Limited | 3.04 Billion INR | -306.635% |
| Indoco Remedies Limited | 17.89 Billion INR | 30.795% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 3.319% |
| Ipca Laboratories Limited | 76.22 Billion INR | 83.753% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -493.377% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -2356.075% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -1086.936% |
| Laurus Labs Limited | 50.01 Billion INR | 75.241% |
| Lupin Limited | 200.1 Billion INR | 93.811% |
| Mankind Pharma Limited | 103.34 Billion INR | 88.017% |
| Medicamen Biotech Limited | 1.79 Billion INR | -590.657% |
| Medico Remedies Limited | 1.44 Billion INR | -754.529% |
| Megasoft Limited | 373.95 Million INR | -3211.619% |
| Piramal Pharma Limited | 81.71 Billion INR | 84.844% |
| RPG Life Sciences Limited | 5.82 Billion INR | -112.764% |
| Sigachi Industries Limited | 3.98 Billion INR | -210.408% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -1539.268% |
| Unichem Laboratories Limited | 16.57 Billion INR | 25.282% |
| Wanbury Limited | 5.75 Billion INR | -115.129% |
| Windlas Biotech Limited | 6.3 Billion INR | -96.272% |
| ZIM Laboratories Limited | 3.67 Billion INR | -237.046% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 93.49% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -7.568% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -193.993% |
| Bal Pharma Limited | 3.39 Billion INR | -265.07% |
| Strides Pharma Science Limited | 40.51 Billion INR | 69.431% |
| Venus Remedies Limited | 5.91 Billion INR | -109.382% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 31.788% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 26.465% |
| Shilpa Medicare Limited | 11.51 Billion INR | -7.536% |
| Aarti Drugs Limited | 25.28 Billion INR | 51.024% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 41.557% |
| Suven Life Sciences Limited | 116.92 Million INR | -10490.957% |
| Ind-Swift Limited | 5.02 Billion INR | -146.461% |
| Valiant Laboratories Limited | 1.82 Billion INR | -580.22% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 64.457% |
| Themis Medicare Limited | 3.81 Billion INR | -224.389% |
| Hikal Limited | 17.84 Billion INR | 30.607% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 88.323% |
| Sequent Scientific Limited | 13.69 Billion INR | 9.589% |
| Novartis India Limited | 3.35 Billion INR | -269.591% |
| Wockhardt Limited | 27.89 Billion INR | 55.597% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 81.525% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -2993.245% |
| Neuland Laboratories Limited | 15.58 Billion INR | 20.544% |
| Morepen Laboratories Limited | 17.01 Billion INR | 27.235% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -702.209% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -235.976% |